Angiolab, Inc. (XKON:251280)
South Korea · Delayed Price · Currency is KRW 3,000.00
+360.00 (13.64%)
At close: Aug 21, 2026
Angiolab Market Cap
Angiolab has a market cap or net worth of 10.48 billion as of August 21, 2026. Its market cap has decreased by -34.71% in one year.
Market Cap
10.48B
Enterprise Value
n/a
Revenue
702.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
3,000.00
ChartMarket Cap Chart
Since April 5, 2017, Angiolab's market cap has increased from 8.46B to 10.48B, an increase of 23.81%. That is a compound annual growth rate of 2.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 10.48B | 21.95% |
| Dec 30, 2025 | 8.59B | -62.64% |
| Dec 30, 2024 | 22.99B | 34.78% |
| Dec 28, 2023 | 17.06B | -12.06% |
| Dec 29, 2022 | 19.40B | -6.10% |
| Dec 30, 2021 | 20.66B | -31.24% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eutilex.Co.,Ltd | 35.32B |
| Epibiotech | 33.43B |
| Quratis | 32.72B |
| Poongjeon Pharmacy CO.,LTD. | 22.19B |
| Shaperon | 21.64B |
| Moogene Medi | 20.56B |
| Plumbline Life Sciences | 18.69B |
| NGeneBio | 15.14B |